CHRISTINE GONZALES: Open Payments
NPI 1669026704 · ELSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 20 payments from 10 companies in 2025. Trend: 2023 $29 · 2024 $0 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $81 |
| Amgen Inc. | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: FREESTYLE LIBRE 3, FARXIGA, Kerendia, MOUNJARO, AFINION 2, GEMTESA, EVENITY, OTEZLA.
Industry payments across TX — which companies pay providers there.
